All articles by Andrew Turley – Page 4
-
Business
BP to pay £4.5 billion for disaster
Company will plead guilty to criminal charges including felony manslaughter
-
BusinessWhat lies within
Bayer boss Marijn Dekkers aims to increase impact of good R&D across different internal units
-
Business
DSM buys food ingredients firm
$634 million deal for Fortitech will expand ‘value chain presence’
-
Business
Takeda buys Envoy for $140m
The small US biotech will boost Takeda’s drug discovery efforts
-
Business
Approval for first gene therapy drug
Glybera (alipogene tiparvovec) injections have been approved in Europe
-
Business
Panel delivers final PFOA report
Probable link between perfluorooctanoic acid, used by DuPont to make fluoro-polymers, and high cholesterol
-
Business
Novartis biotech plant for Singapore
Firm will invest $500 million in biotech manafacturing
-
BusinessChemists contribute to prior art hunt
A crowdsourcing website that pays for prior art is gaining popularity – can chemists make money?
-
Business
More jobs go: Lonza cuts 500
A bid to ‘secure the future’ of the site at Visp in Switzerland
-
Business
Patent woes lead to sharp sales losses
Bristol-Myers Squibb, AstraZeneca and Eli Lilly have all suffered loss of exclusivity for key drugs
-
Business
Bankruptcy for US Li ion battery maker
Johnson Controls to buy the automotive business of A123 Systems for $125 million
-
Business
Pfizer to pay $700m for Ritalin re-formulated
Pfizer to buy a company with a liquid formulation of historic ADHD drug methylphenidate
-
Business
$2.2bn speciality chemicals acquisition
Family-owned US speciality chemical company Champion Technologies is to be bought by Ecolab
-
Business
Carbon dioxide to chemical partnership
Petronas to partner with gas fermentation specialist LanzaTech
-
News
Pharma should 'double output by 2022'
US report says pharma industry must set itself an ambitious target for drug development